Muskil, Ailyn .
HRN: 26-57-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFTRIAXONE 1G (VIAL)
01/23/2025
01/30/2025
IVT
1750 Mg
Q 24h
T/c Mild TBI; Multiple Soft Tissue Injuries Sec To MVA; S/P Wound Suturing (01/23/25)
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes